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Abstract
Background:  Systematic search for genes whose gain-of-function by exogenous expression
confers an advantage in cell-based selective screenings is a powerful method for unbiased functional
exploration of the genome, and has the potential to disclose new targets for cancer therapy. A
major limit of this approach resides in the labor-intensive cloning of resistant cells, identification of
the integrated genes and validation of their ability to confer a selective advantage. Moreover, the
selection has to be drastic and genes conferring a limited advantage are typically missed.
Results: We developed a new functional screening strategy based on transduction of mammalian
cells of a given species with an expression library from another species, followed by one-shot
quantitative tracing with DNA microarrays of all library-derived transcripts before and after
selection. In this way, exogenous transcripts enriched after selection, and therefore likely to confer
resistance, are readily detected. We transduced a retroviral cDNA expression library from mouse
testis into human and canine cells, and optimized the use of commercial murine gene expression
arrays for species-specific detection of library-derived transcripts. We then conducted a functional
screening by growing library-transduced canine MDCK cells in suspension, to enrich for cDNAs
conferring anchorage independence. Notably, these cells show partial resistance to loss of
anchorage, and the selection can be of limited stringency, compromising approaches based on
clonal selection or anyway requiring high stringency. Microarray analysis revealed reproducible
enrichment after three weeks of growth on polyhema for seven genes, among which the Hras
proto-oncogene and Sox5. When individually transduced into MDCK cells, Sox5 specifically
promoted anchorage-independent growth, thereby confirming the validity and specificity of the
approach.
Conclusion:  The procedure described here brings substantial advantages to the field of
expression cloning, being faster, more systematic and more sensitive. Indeed, this strategy allowed
identification and validation of genes promoting anchorage-independent growth of epithelial cells
under selection conditions not amenable to conventional expression cloning.
Published: 29 May 2008
BMC Genomics 2008, 9:254 doi:10.1186/1471-2164-9-254
Received: 28 February 2008
Accepted: 29 May 2008
This article is available from: http://www.biomedcentral.com/1471-2164/9/254
© 2008 Martelli et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
Page 2 of 13
(page number not for citation purposes)
Background
Functional screenings based on the gain-of-function
approach proved extremely valuable in the identification
of novel genes involved in key processes related to cancer
onset and progression, such as neoplastic transformation,
resistance to apoptosis, or escape from senescence [1-3].
Identification of a gene whose expression confers neoplas-
tic properties to normal cells, or renders cancer cells resist-
ant to death-promoting stimuli or drugs, directly defines
that gene as a potential target for novel therapeutical strat-
egies. Screenings of this type are usually performed in
mammalian cells by transducing an expression library
containing full length cDNAs into a given target cell line.
Then a selective stress capable of strongly reducing cell
viability and proliferative potential is applied. Only cells
expressing exogenous cDNAs conferring resistance to the
selection will grow and form resistant colonies [4]. Then,
a huge amount of work is typically required to identify the
integrated cDNAs in the resistant colonies, and to verify
that they effectively mediate the selective advantage.
Moreover, the selection has to be drastic to avoid the
emergence of spontaneously resistant colonies, which
would dramatically increase the number of false hits. As a
consequence, this approach does not allow identification
of genes conferring a limited advantage per se and poten-
tially synergizing with others. Different strategies have
been developed to overcome at least in part these limita-
tions, such as vector mobilization and re-screening [5], or
gene capture by recombination [6]. These approaches
reduced the amounts of false hits to be analyzed, but were
still quite labor intensive and required multiple screening
cycles.
Here we introduce a novel approach, that we named
"xenoarray analysis" (Figure 1), in which standard gene
expression arrays are used for tracing the abundance of
exogenous cDNAs derived from the library, before and
after selection, without the need of isolating clones and/
or of performing multiple screening cycles. To enable spe-
cific detection of library-derived cDNAs, the species of ori-
gin of the expression library has to be different from that
of the target cells. In this way, endogenous and exogenous
transcripts are from different species, and sequence diver-
gence between orthologue transcripts can be exploited as
a "molecular barcode" for species-specific hybridization
on microarrays. The molecular barcoding approach has
been originally developed for genetic screens in yeast [7],
and subsequently employed for screenings with shRNA
libraries in mammalian cells [8,9]. In those cases, the bar-
codes were artificial sequences whose detection required a
dedicated microarray. In the present approach, the bar-
codes are naturally embedded in the library-derived tran-
scripts. Therefore, commercial expression arrays could in
principle be used for the task, especially because many
probes are designed on the 3'-untranslated regions of the
transcripts, which are particularly divergent across species
[10]. To verify the potential of the approach, we assessed
the species-specificity of probes contained in commercial
expression arrays, defined their sensitivity on human and
dog cells transduced with a mouse expression library and
conducted a selective screening aimed at identifying genes
rendering epithelial cells capable of growing on the
absence of anchorage, a well-know feature of the neoplas-
tic transformation process.
Results
Commercial gene expression arrays are species-specific
To assess whether commercial expression arrays can be
used for species-specific detection of exogenous tran-
scripts within a background of endogenous transcripts, we
analyzed the 46133 50-mer probes of Mouse-6_V1 expres-
sion arrays from Illumina. We noticed that 18019 out of
32826 annotated probes (55%) hybridize with at least 25
bases to the 3'-UTR or 5'-UTR regions of the correspond-
ing mouse transcripts. Given the higher level of interspe-
Schematic outline of the Xenoarray analysis procedure Figure 1
Schematic outline of the Xenoarray analysis proce-
dure. An expression library from species A is transduced 
into target cells of species B. Efficient expression of the exog-
enous transcripts can be checked at this stage by comparing 
transduced and untransduced cells on microarrays for spe-
cies A. Transduced cells are then subjected to a selective 
pressure to enrich for cells carrying exogenous cDNAs con-
ferring resistance. Finally, comparing microarray signal inten-
sities before and after selection allows simultaneous 
detection of all enriched exogenous transcripts, without the 
need of cloning resistant colonies to identify the integrated 
sequences.BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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cies sequence variation in the UTR regions [10], such
probes are expected to be species-specific. To further
extend the analysis, each probe was blasted against the
mouse, human and dog transcriptome, to check for
potentially cross-species hybridizing probes (Figure 2A).
According to this analysis, only a small fraction (about
5%) of the mouse array probes is likely to efficiently
hybridize to the corresponding human or dog transcripts.
As a control of the coverage, over 80% of the murine
probes found a perfect match in the mouse transcriptome.
Therefore, the commercial arrays analyzed can in princi-
ple be used for Xenoarray analysis, without the need of a
specific design. To facilitate identification and filtering of
probes giving cross-hybridization signals, and subsequent
assessment of exogenous transcript enrichment after the
selection, we implemented a software named Xenoarray
Analysis Studio (XAS). XAS enables reading and display-
ing gene expression data from wild-type and transduced
cells, before and after selection, filtering non-specific
probes, and comparing selected and unselected cells to
identify enriched exogenous transcripts.
Setup of Xenoarray analysis
To set-up the procedure, we transduced human HeLa cells
with a retroviral mouse testis expression library at the esti-
mated multiplicities of infection (MOIs) of ~1.25, ~2.5
and ~5 (for assessment of transduction efficiency, see
Materials and Methods). The Scatter Plot in Figure 2B
illustrates the results of gene expression profiling on con-
trol and transduced cells at MOI ~1.25, using Illumina
Mouse_Ref-8_V1 arrays, and following the standard pro-
cedure with a higher amount of RNA (1 μg) and double
reagents and reaction volume. Clearly the amount of
exogenous transcripts specifically detected (less than 400)
was not adequate for a systematic screening and required
improvement. To increase detection of exogenous tran-
scripts and decrease cross-hybridization with endogenous
ones, we modified the procedure by introducing a vector-
specific primer for reverse transcription (T7-pFB) and
optimizing all the subsequent steps (detailed in Meth-
ods). The results obtained with this optimized protocol at
the same MOI are shown in Figure 2C. The number of
probes giving significant signal (detection > 0.99) in
transduced cells was 1605. Conversely, only 285 probes
gave significant signal in untransduced cells, indicating
that over 1300 exogenous transcripts were specifically
detected in transduced cells. The low background is due
not only to the use of the T7-pFB primer, but also to the
fact that non-specific reverse transcription of endogenous
human RNAs by the pFB primer produces human cRNAs
that do not hybridize efficiently to the murine array.
Indeed, when the T7-pFB primer was used to reverse-tran-
scribe a human RNA from wild-type cells and the corre-
sponding cRNA was hybridized on human arrays, the
background raised from less than 300 probes to over 1600
probes (data not shown).
To evaluate whether a higher MOI could increase detec-
tion of library-derived genes, Xenoarray analysis was per-
formed also on the populations transduced at MOI ~2.5
and ~5, using the standard or the T7-pFB primer for cDNA
synthesis. The analysis confirmed that use of the T7-pFB
primer increased detection of library-derived transcripts
also at higher MOIs (Figure 2D). Notably, the number of
library-derived transcripts reached a plateau at MOI ~2.5
for both primers. Specific detection of almost 1700
murine transcripts at this MOI further confirmed the effi-
ciency of retroviral expression libraries as a tool for func-
tional screenings [2]. In view of the fact that, by average,
9000–10000 transcripts are typically detected in a micro-
array experiment with Illumina beadchips, we estimated
that Xenoarray analysis detects the 15–20% most repre-
sented exogenous cDNAs. Rarer cDNAs are not detected in
the initial transduced population, but may become detect-
able if enriched by the selection procedure. To estimate
the enrichment rate required to render a rare cDNA detect-
able after selection, we exploited a key feature of gene pro-
filing based on Serial Analysis of Gene Expression (SAGE),
i.e. the absolute abundance of each transcripts measured
as parts per million (PPM) [11]. In particular, we analyzed
the distribution of the abundance of transcripts available
from a published SAGE analysis on mouse testis [12]. We
observed that, like a typical microarray experiment, SAGE
identified around 10000 transcripts, and the 1700 most
abundant ones had a representation of 76 PPM or higher,
while the remaining transcripts had a representation of 8
to 76 PPM [see Additional file 1]. Based on this analysis,
a 10-fold enrichment of a rare transcript should be
enough to render it detectable by Xenoarray analysis.
Xenoarray analysis identifies genes promoting anchorage-
independent growth
HeLa cells are already transformed, highly proliferative
and anchorage independent [13]. Therefore, even if their
genome is remarkably stable [14], they are not optimal for
selective screenings. We therefore focused on canine
MDCK cells as a possible model for expression cloning of
genes conferring anchorage independence. When cultured
in the absence of anchorage, for instance on polyhema-
coated dishes, these cells reduce their growth rate and
undergo programmed cell death [15]. For the functional
screening, MDCK cells were transduced at MOI ~2 with
the mouse testis library or with GFP as control. Subse-
quently, the transduced cells were expanded, split and cul-
tured on regular plates or selected on polyhema-coated
plates, as described in Methods, to generate four popula-
tions: GFP-transduced unselected (GFP-UNS), GFP-trans-
duced selected (GFP-SEL), library-transduced unselected
(LIB-UNS) and library-transduced selected (LIB-SEL).BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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Feasibility and setup of xenoarray analysis Figure 2
Feasibility and setup of xenoarray analysis. (A) Cross-species BLAST analysis for 50-mer probes from Illumina Mouse 
Whole Genome chip V1, against transcriptome databases for murine, human and canine transcripts. The best match for each 
probe was chosen as the BLAST hit with the highest number of identical nucleotides and the lowest e-value for significance. 
The histogram shows the distribution of the number of identical nucleotides between the probes and their best hits, respec-
tively in the Murine, Canine and Human transcriptomes, as indicated. (B, C) Xenoarray analysis on untransduced and library-
transduced HeLa cells (MOI ~1.25) using the T7-dT primer (B) or the T7-pFB primer (C). In these dot plots, each dot repre-
sents a probe signal, the coordinates of which are given by the intensity in the untransduced (x-axis) and in the transduced (y-
axis) cell samples. Murine transcripts, specifically detected by the murine microarray only in the transduced cells, are high-
lighted by a continuous red circles. Endogenous human transcripts, giving cross-hybridization signals in both samples, are high-
lighted by a dotted red circle. (D) Numbers of probes giving significant signal using T7-dT or T7-pFB primers for Xenoarray 
analysis on HeLa cells transduced with the retroviral library at different MOI, from 0 (CTRL) to 5, as indicated.BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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Xenoarray analysis on MDCK cells Figure 3
Xenoarray analysis on MDCK cells. (A) Dot plot comparing the signal intensity for GFP-transduced and library-trans-
duced cells, as indicated. Murine transcripts, specifically detected by the murine microarray only in the transduced cells, are 
highlighted by a continuous red circles. (B) Growth curve on control and selected populations. The x-axis shows the time, the 
y-axis the percent of viable cells number, compared to 100% at day 0. The data represent the mean and standard deviation of 
triplicate values. (C) Soft agar growth on control and selected populations. Segmentation of single colonies and analysis of the 
relative diameters were performed by the Attovision 1.5 software (BD biosciences) on images captured by a BD Pathway sys-
tem (BD biosciences). Briefly, a threshold of colony size was defined as the 95th percentile of the colony size in pictures taken 
from the GFP-UNS cells. Then the number of colonies above the threshold was calculated for all fields (8 fields/sample). The 
bar chart indicates the average and standard error of the number of colonies/field above the threshold for the GFP- or library-
transduced cells, unselected or selected on polyhema, as indicated. (D, E) Xenoarray analysis on library-transduced MDCK 
cells before (x-axis) and after (y-axis) selection, performed on first infection (D) and second infection (E). The red circles indi-
cate the area grossly corresponding to transcripts enriched in selected cells.BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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Xenoarray analysis comparing the GFP-UNS and LIB-UNS
populations resulted in the specific detection of almost
1700 library-derived transcripts in the MDCK background
(Figure 3A).
The four populations were also assayed for proliferation
in adherence conditions and in soft agar (Figure 3B, C).
The LIB-SEL population displayed the highest growth rate
in adherence, and formed much larger colonies in soft
agar compared to LIB-UNS cells (p < 0.0025). A slightly
increased growth was also observed for GFP-SEL com-
pared to GFP-UNS cells (p < 0.021), possibly highlighting
insertional mutagenesis events which frequently occur
with retroviral vectors [16]. However, such events cannot
explain the greater increase observed in the LIB-SEL pop-
ulation (LIB-SEL vs GFP-SEL: p < 0.02), which therefore is
likely to derive from expression of advantageous exoge-
nous transcripts. To identify these transcripts, we per-
formed xenoarray analysis comparing LIB-SEL vs. LIB-
UNS cells (Figure 3D), and observed a significant number
of transcripts detected at higher levels in selected cells.
Interestingly, no library-derived transcripts are less abun-
dant after selection. This indicates a limited stringency of
the selection, allowing even rare populations to remain
represented. In fact, we noticed that after an initial crisis
in the first two days of culture in suspension, MDCK cells
adapted to the condition by forming aggregates and
reducing the proliferation rate, without massive cell
death. More drastic selection procedures, such as crossing
a transwell membrane and "diving" to the bottom of the
well, induced loss of the majority of the library-derived
transcripts (data not shown). To validate reproducibility
of the selection within the same transduced population, a
second selection had been conducted in parallel on the
library-transduced cells described above ("Selection B").
Table 1: Library-derived genes enriched in MDCK cells by two independent selections for anchorage independent growth.
Gene Symbol Illumina Probe ID Fold Enrichment Selection A Fold Enrichment Selection B
Rad9b 2320064 128.77 34.88
Dhx32 2680138 103.32 49.42
Mos 5290619 55.78 12.74
Ndufv1 5420369 23.51 13.24
Hras1* 102650273 15.61 60.95
Cct2 1690113 12.13 4.90
Ldh1 2190594 10.28 8.86
Akap4 2190731 10.02 3.59
Hras1* 1980551 6.01 20.26
Mcm5 2680647 5.68 20.58
Maea 105890102 5.29 22.17
LOC331507 104760139 5.11 25.23
LOC271374 106400687 3.76 2.89
Sox6 6840717 3.64 11.39
Ncoa5 2060647 3.49 2.41
Sox5* 3190128 3.20 11.25
Temt 2320020 3.07 4.14
Fbxo6b 5690692 2.79 2.46
Sox5* 2370576 2.78 10.70
Eif2b5* 430315 2.10 2.77
Hnrpc 1570133 2.01 6.22
Eif2b5* 6900400 2.01 4.36
4933424G06Rik 1240736 145.86 66.80
5730438N18Rik 5340138 123.87 46.01
4930528F23Rik 6620368 101.24 27.16
1110003A17Rik 7000446 16.18 92.78
2700067E09Rik 3440286 11.19 48.48
8030459N02Rik 101450446 5.78 11.78
4921511C04Rik 4070411 3.55 10.61
0610007P22Rik* 130193 3.42 10.02
2500001K11Rik 5080577 3.20 9.36
0610007P22Rik* 3800433 3.16 16.36
0610007P22Rik* 6020750 2.39 13.03
2610510J17Rik 5390500 2.26 4.23
Array probes displaying increased signal in selected cells by 2-fold or higher were compared across the two selections using the XAS software. 
Genes appearing more than once in the table (tracked by multiple probes) are highlighted by an asterisk.BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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Similarly, also the LIB-UNS population was split in two
for replicate analysis (LIB-UNS A and LIB-UNS B). Also in
Selection B, Xenoarray analysis highlighted enriched tran-
scripts [see Additional file 2]. To verify if the same tran-
scripts were enriched in both selections, we calculated the
log2 ratio between the signals in selected and unselected
cells for each transcript in each selection, and compared
the results of the two selections. Over 70 percent of the
genes enriched more than 2-fold in selection A were also
enriched over 2-fold in selection B. To validate the 2-fold
threshold for significant enrichment, we compared
Xenoarray data obtained from the two LIB-UNS popula-
tions. Only two probes gave a fold-change higher than 2
(2.08 and 2.04) in this control comparison.
The 29 genes (detected by 34 probes) reproducibly
enriched over 2-fold in both selections are listed in Table
1. In addition to poorly characterized genes, the screening
highlighted proto-oncogenes like Hras1, Mos and Rad-9b,
known to be capable of transforming cells, conferring
anchorage independence and/or promoting cell prolifera-
tion [17-19].
To verify the specificity of the selection hits, we carried out
two alternative selection procedures, one based on serum
withdrawal, and therefore not involving anchorage inde-
pendence, and the other based on the crossing of a tran-
swell membrane and "diving" to the bottom of the plate,
more directly linked to anchorage independence. Then we
compared the enrichment of the 34 probes emerged from
polyhema selection with the enrichments observed in
these two selections [see Additional file 3]. While no cor-
relation was observed between polyhema selection and
serum withdrawal (Pearson = -0.32), a striking concord-
ance was observed between polyhema and transwell "div-
ing" selections (Pearson = 0.94). These results confirm
that cDNA enrichment is not just the result of a general
tendency of a subpopulation of cells to overgrow, but
rather is specifically driven by the type of selection.
Reproducible enrichment of exogenous cDNAs by parallel
selection in the same transduced population does not rule
out two main possible artefacts: (i) enrichment may
derive from deregulation of an endogenous gene by inser-
tional mutagenesis; (ii) a very small subpopulation of
resistant cells may exist from the beginning, and a cDNA
transduced in these cells may get reproducibly enriched by
carryover.
Therefore, to further validate the screening hits, we per-
formed a second, independent transduction of MDCK
cells with the mouse testis library ("Infection 2"), using a
lower MOI (~1). It should be noticed that double or triple
infection of the same cell is not a problem for the xenoar-
ray approach, because in the one-shot analysis the selec-
tion drivers will be present in all selected cells, while the
bystanders will be diluted out. The lower MOI was chosen
to reduce the possibility of phenotypes deriving from
insertional mutagenesis. Again, after expansion, the cells
were split to generate unselected and selected popula-
tions. Xenoarray on LIB-SEL vs LIB-UNS populations from
this second infection was then compared with the results
of the first infection (Figure 3E). Even with a lower MOI,
Xenoarray analysis identified several enriched transcripts;
those reproducibly enriched over 2-fold in both inde-
pendent screenings are listed in Table 2. Notably, Hras1
enrichment was confirmed, albeit less evident, and the
Sox5 and Sox6 transcription factors displayed the highest
concordant enrichment.
Repetition of the transduction and selection procedure led
to a limited validation of the hits identified in the first
screening. This result corroborates the idea that process
streamlining allowed by the xenoarray approach should
be exploited for performing multiple independent screen-
ings, thereby allowing identification of more consistent
hits. However, it should be noted that genes enriched in
only one transduction-selection experiment are not neces-
sarily false hits. Indeed, the complexity of the integrated
cDNA repertoire can vary across independent transduc-
tion experiments. This is particularly true for rare tran-
Table 2: Library-derived genes enriched in MDCK cells by two independent infections and selections for anchorage independent 
growth.
Gene Symbol Illumina Probe ID Fold Enrichment Infection 1 Fold Enrichment Infection 2
Sox5 3190128 3.20 42.50
Sox5 2370576 2.78 23.36
Sox6 6840717 3.64 27.78
Hras1 102650273 15.61 4.25
Akap4 2190731 10.02 2.78
4921511C04Rik 4070411 3.55 2.14
Fbxo6b 5690692 2.79 2.58
Hnrpc 1570133 2.01 2.80
Array probes displaying increased signal in selected cells by 2-fold or higher were compared across the two infections using the XAS software.BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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scripts, which may not be represented in one of the two
transduced populations, or may integrate in unfavourable
regions of the host genome. Moreover, rare transcripts
need to be highly enriched to emerge from the microarray
background, and even in that case the differential signal
may not necessarily be greater than 2-fold.
Validation of the ability of SOX5 to promote anchorage-
independent growth
The SOX5 and SOX6 genes encode two highly similar
transcription factors co-expressed in cartilage and essen-
tial for chondroblast proliferation and differentiation [20-
22]. Both of them are overexpressed in gliomas [23,24],
and while SOX6 was recently proposed as a possible
important factor in obesity-related insulin resistance [25],
SOX5 overexpression and amplification has been
SOX5 promotes anchorage-independent growth of MDCK cells Figure 4
SOX5 promotes anchorage-independent growth of MDCK cells. (A) Validation of murine Sox5 enrichment in library-
transduced and polyhema-selected MDCK cells. Ethidium bromide staining of PCR reactions performed on water or on 
cDNAs from GFP- and library-transduced cells, before and after selection, as indicated. (B) Western blot analysis of human 
Sox-5 protein expression in hSOX5-transduced MDCK cells or in GFP-transduced control cells, as indicated. Anti-β-actin was 
used as loading control. (C) Growth curve of GFP- and SOX5-transduced MDCK cells on plastic (adherent) and polyhema 
(suspension). The x-axis shows the time, the y-axis the percent of viable cells number, compared to 100% at day 0. The data 
represent the mean and standard deviation of triplicate values. (D) Sox5 promotes growth in soft agar. The bar chart indicates 
the average and standard error of the number of colonies/field above the threshold for the GFP- or SOX5-transduced cells, as 
indicated (8 fields/sample, p < 0.0002).BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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observed in human testicular seminoma [26]. Moreover,
translocation-driven overexpression of SOX5 has recently
been described in a primary splenic follicular lymphoma
[27], suggesting a potentially wider role for this gene in
cancer. We therefore validated murine Sox5 mRNA enrich-
ment in selected MDCK cells by PCR (Figure 4A), cloned
its human coding sequence into the pFB retroviral vector
and transduced wild-type MDCK cells, using GFP as a con-
trol.
After confirming expression of the exogenous protein by
Western Blot (Figure 4B), SOX5- or GFP-transduced pop-
ulations were assayed for proliferation on plastic sub-
strate, polyhema or soft agar (Figure 4C, D). In all three
assays, increased growth was observed for SOX5-trans-
duced cells compared to the GFP controls. Interestingly,
the growth advantage was more evident when cells were
cultured in the absence of anchorage (1.8-, 2.3- and 2.4-
fold increase, respectively for growth on plastic, polyhema
and soft agar). These data confirm that Xenoarray-based
screenings identify hits with specific biological properties
defined by the type of selection.
Discussion
DNA microarrays have greatly advanced our ability to
identify genes whose expression is associated with partic-
ular phenotypes or biological processes [28,29]. Never-
theless, they have been falling short in determining cause-
effect relationships between genes and phenotypes, espe-
cially in the field of cancer research. Recent and more
direct approaches employed microarrays for "barcode"
screenings with shRNA vectors, to identify genes whose
loss may render cancer cells resistant to selective stresses
[8,9]. However, such genes are not immediately exploita-
ble as therapeutical targets because their blockade is ben-
eficial to cancer cells. Rather, they may provide the
rationale for identifying other druggable genes whose loss
of function is selectively toxic for cancer cells. The poten-
tial usefulness of gain-of-function-based approaches in
cancer research is further confirmed by recent evidence of
the involvement of the PI3K pathway in the resistance of
human breast cancer to the HER2-blocking antibody Tras-
tuzumab. In particular, Berns and colleagues identified
PTEN in an shRNA-based barcode screening for resistance
to Trastuzumab, and then found that the acquisition of
resistance by shRNA-driven loss of PTEN is mirrored by a
much stronger in vitro resistance phenotype driven by
overexpression or mutation of PIK3CA, i.e. by a gain-of-
function approach [30].
All screenings based on selection find a major challenge in
the need of avoiding false hits. Being substantially stream-
lined, the screening described here can be easily repeated
multiple times, which increases the rate of true positive
hits. It should be also noticed that most of the significant
enrichments observed occurred for cDNAs that were not
detected in transduced cells before selection. This further
confirms that the range of functional exploration extends
well beyond the 1700 cDNAs already detectable in unse-
lected cells. The xenoarray approach does not directly
address a key bottleneck for expression library-based
screens, i.e. their reliance on high quality, representative
cDNA collections and the ability to efficiently introduce
these genes into mammalian cells. However, xenoarray
analysis comparing transduced and untransduced cells
can be used for the optimization of library construction
and transduction, allowing a one-shot measurement of
the complexity of the transduced library. A specific caveat
to be considered is that the xenoarray approach assumes
functional conservation between orthologous proteins.
However, functional conservation across mammalian spe-
cies is generally the rule rather than the exception, and sin-
gle hit functional conservation can be further checked
using orthologous proteins databases such as P-POD [31].
Moreover, hit validation would typically imply transduc-
tion of the target cells with an ORF derived from their spe-
cies of origin, or RNAi-based targeting of the endogenous
gene, which would further support the biological rele-
vance of the finding.
Our data show that one of the identified murine genes,
SOX5, actually promotes anchorage-independent growth
of MDCK epithelial cells also when exogenously
expressed in its human version, and further support a pos-
sible role for this gene in tumor onset and progression.
The third-best hit of the screening, Hras1, is a well-known
proto-oncogene, and its ability to confer anchorage inde-
pendence to normal cells has been well documented [32].
The most frequent mechanism of activation of RAS-family
genes is point mutation [17]. However, increased expres-
sion of normal RAS proto-oncogenes due to gene amplifi-
cation has also been reported to occur in human cancer
[33]. Therefore, the finding of this gene as a hit can be
considered as a positive control of the screening effi-
ciency. Existing knowledge about the other screening hits
is compatible with their potential role in anchorage-inde-
pendent growth as well. Hnrpc encodes an mRNA-bind-
ing protein found to stabilize the mRNA and to increase
expression of the urokinase receptor [34], a well-known
player in cancer onset and progression [35]. The Akap4
gene is expressed only in the postmeiotic phase of sperma-
togenesis and its protein product anchors cAMP-depend-
ent protein kinase A in a restricted region of the
mammalian sperm flagellum [36]. Its overexpression in
MDCK is therefore likely to drive PKA activation and relo-
calization to the cytoskeleton, thereby affecting cell motil-
ity and adhesion. However, due to its extremely restricted
expression, this gene is unlikely to physiologically pro-
mote anchorage independence in epithelial cells. Fbxo6b
is a member of the E3 glycoprotein-specific ubiquitinBMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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ligase family, playing a role in endoplasmic reticulum-
associated degradation [37]. Its overexpression may there-
fore promote anchorage-independent growth by modify-
ing the expression pattern of transmembrane
glycoproteins. Given the low stringency of the polyhema
growth selection on MDCK cells, which did not reduce the
repertoire of library-derived transcripts detected by the
xenoarray after the selection, it is likely that many of the
above-described hits provide only a limited advantage,
and could not be detected by a classical approach based
on more drastic selection strategies. In this view, it will be
interesting to assess their possible reciprocal cooperation.
The procedure described here employs full-length cDNA
expression libraries derived from a given tissue or cell line,
which brings advantages and disadvantages, compared to
arrayed collections of open reading frames (ORFs). The
main disadvantage of using libraries is that some genes
may fail to be represented and others may be overrepre-
sented. In this view, Xenoarray analysis could also be
applied to ORF collections, which would allow a much
tighter control on the composition and relative abun-
dance of the cDNAs used for the screening, as well as
focused exploration of gene subsets. In this case, however,
it should be noted that the majority of the probes of com-
mercial expression arrays fall outside of the transcripts'
ORFs. Therefore, custom species-specific expression arrays
should be designed to cover areas of non-homology
within the ORF regions. As an advantage, libraries provide
a more comprehensive repertoire of all the transcripts and
of their isoforms expressed in the tissue of origin, thereby
being more explorative. Moreover, when expression
libraries are derived from cancerous tissues or cells, this
approach can be combined with resequencing of the hits
to highlight mutated genes, potentially exploitable as
therapeutical targets. It therefore provides a powerful tool
for the dissection of the mechanisms of cancer onset and
progression and of resistance to anti-neoplastic treat-
ments.
Conclusion
The Xenoarray technology described here provides a new,
efficient approach to expression cloning and functional
genomics. It takes full advantage of genome-wide expres-
sion profiling to identify genes that confer resistance to a
specific selective stress, thereby establishing a cause-effect
relationship. Being more sensitive and systematic, the
procedure does not require extreme selection stringency
and isolation of resistant individual clones. In this way,
also genes conferring a partial advantage can be identified
and further explored for their possible reciprocal cooper-
ation.
Methods
Cell Culture, Reagents and viral transduction
Madin-Darby canine kidney (MDCK) cells and HeLa cells
were from ATCC. They were cultured in Dulbecco's mod-
ified Eagle's medium (DMEM) (Gibco) supplemented
with 10% FBS (Sigma) in a humidified atmosphere of 5%
CO2. The mouse testis retroviral expression library, pack-
aged in the VSV envelope was purchased from Stratagene
(ViraPort, Cat n. 972300). To titer the library viral super-
natant, we used a GFP retroviral supernatant provided by
the manufacturer at the same titer, seeding 5*104 cells
onto 35 mm tissue culture plates. The following day, 1 ml
of dilutions from 10-1 to 10-5 of the pFB-hrGFP retroviral
supernatant in growth medium supplemented with 10
μg/ml DEAE-dextran (Amersham Bioscence) were added
to each well. After 3 hours, an additional 1 ml of growth
medium was added to each well. GFP expression analysis
was performed after 48 hours by flow cytometry: cells
were trypsinized, diluted in a 1% paraformalhdeide-2%
FBS solution and analyzed on a FACS Calibur flow cytom-
eter (Becton Dickinson). The titer of the library, expressed
as GFP transduction units (TU) per ml, was calculated as
105 (the number of infected cells) times the fraction of
green cells times the dilution factor. HeLa transduction
experiments were performed by plating 5*104 cells in 35
mm wells. After one day, 1 ml of library supernatant dilu-
tions prepared as above were added. Medium with no
virus was added to generate an uninfected control. The
plates were returned to 37° for 3 hours, then 1 ml of
growth medium was added to each well. After 48 hours
infected and control cells were expanded and used for
microarray analysis. MDCK transduction was performed
as above, except that 5*105 cells were infected with about
1*106 TU of viral supernatant in 60 mm dishes (MOI = 2).
The pFB-hrGFP retroviral supernatant was used at the
same MOI as a control. After 48 hours library- and GFP-
infected cells were expanded for the functional screening.
Genomic analysis of probes cross-hybridization
Probes cross-hybridization analysis was performed by
blasting all the probes from the Illumina Mouse-6_V1
chip against the transcriptome databases from Ensembl
(release 91. The interrogated databases were the
mm_cdna35 and est_mus for mouse, hs_cdna36 and
est_hum for human. Dog transcripts were obtained from
cf_cdna_broadd1 and est_mam, which required filtering
to exclude non-canine transcripts. The blastjob run was
launched according to the following parameters:
$ blastall -p blastn -i fasta -d "database" -v 100 -b 100 -o out 
-a 2 -W 7 -m 7,
where the W parameter sets the alignment seed to 7 bases.
The blast output data were parsed with a Perl script to dis-BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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play the number of identical nucleotides between each
probe and its best hit.
Anchorage-independent growth selection
Polyhema-coated 100 mm Petri dishes were prepared by
applying 4 ml of a 12 mg/ml solution of poly-hydroxy-
ethyl-methacrylate (polyhema; Sigma) in ethanol, drying
under tissue culture hood, repeating the application once
and incubating the plates overnight at 37°C. For the selec-
tion, after trypsinization, 1.5 × 106 cells were plated onto
polyhema plates and cultured for one week, removing cell
debris by spinning the suspension at low speed (400 rpm)
and resuspending the pellet in fresh medium every 2–3
days. Cells were then allowed to recover on normal dishes
for 24 hours, after which the selection was repeated for a
total of 3 cycles. Selected cells were expanded on regular
plates for one week before being used for microarray anal-
ysis and functional assays.
Adherent and suspension growth assays
For cell viability assays, 103 cells of each cell line were
seeded in triplicate in 96-well plates, one for each time of
the growth curve assay, both on plastic and on Polyhema
coated plates. The day after, a tetrazolium salt-based rea-
gent (CellTiter96 Aqueous One Solution, Promega) was
added to each well according to the instructions provided
by the manufacturer. After an incubation of 2 h, absorb-
ance was read at 490 nm on a DTX 880 plate reader (Beck-
man Coulter, Milan, Italy). For the soft agar growth assay,
104 cells were resuspended in 1 ml of 0.5% top agar (Sea-
Plaque Agarose, Cambrex, UK) in growth medium and
seeded in 6-well plates previously coated with 2 ml of 1%
basal agar in growth medium. The assay was performed in
duplicate. After 2 weeks, phase-contrast pictures were cap-
tured and analyzed with a BD Pathway Workstation.
RNA extraction and processing for microarray analysis
RNA was extracted using the TRIzol reagent (Invitrogen),
according to the manufacturer's protocol, and then fur-
ther purified using the RNeasy Mini kit from Qiagen. The
quantification and quality analysis of RNA was performed
on a Bioanalyzer 2100 (Agilent). Synthesis of cDNA and
biotinylated cRNA was performed using the Illumina
TotalPrep RNA Amplification Kit (Ambion Cat. n.
IL1791), according to the manufacturer's protocol, with
the following variations to optimize xenoarray analysis:
(i) standard cDNA synthesis with the T7-dT(24) primer: 1
μg of total RNA was used, with the doubling of the reac-
tion volume and of all reagents; (ii) library-specific cDNA
synthesis: 20 μg of total RNA were used with 4 pm of a
pFB-specific primer (T7-pFB, sequence: GGCCAGT-
GAATTGTAATACGACTCACTATAGGGAGGCGGCGAAC-
CCCAGAGTCCCGCTCA, HPLC-purified from Sigma)
with standard reaction conditions. The T7-pFB primer
contains the T7 promoter (for cRNA synthesis) followed
by a vector-specific sequence, which is present in the 3'
region of all transcripts derived from the library. Quality
assessment and quantification of cRNAs were performed
on Bioanalyzer 2100.
Hybridization of HeLa-derived cRNAs was carried out for
18 hours on Illumina Mouse_Ref-8_V1 arrays (Cat. N.
BD-26-201) according to the manufacturer's protocol,
using 15 μg of T7-dT(24)-derived cRNA or 1.5 μg of T7-
pFB-derived cRNA. These arrays contain circa 24000
probes exploring the transcripts contained in the Refseq
database, and therefore more reliable. Hybridization of
MDCK-derived cRNAs was carried out on Illumina
Mouse-6_V1 arrays (Cat. N. BD-26-101), using 1.5 μg of
T7-pFB-derived cRNA. These arrays contain all the RefSeq
probes present in the Mouse_Ref_8_V1 arrays, plus addi-
tional 24 k probes exploring less characterized transcripts,
additional Unigene clusters and singletones, to allow a
more complete coverage of the transcriptome. Array wash-
ing was performed using Illumina High-stringency wash
buffer for 30 min at 55°C, and followed by staining and
scanning according to standard Illumina protocols. Probe
intensity and detection data were obtained using the Illu-
mina BeadStudio software, and further processed with the
XAS software. Microarray data are available at GEO, data-
set GSE11721.
Xenoarray data analysis
The Xenoarray analysis pipeline was implemented in the
XAS software (C++ with QT library from Trolltech [38])
and subdivided in 3 main tasks: (i) Removal of probes
cross-hybridizing to endogenous transcripts. For this task,
the "Detection" value provided by the Illumina Beadstu-
dio software was used. This value ranges from 0 (non
detected) to 1 (detected), with 0.99 or higher as the usual
thresholds for significant detection. All probes with a
Detection value higher than the threshold set by the user
in untransduced cells are excluded from the subsequent
steps. (ii) Data preprocessing to improve reproducibility,
and reduce technical noise. The data can be either rank
invariant normalized or scaled according to the tenth per-
centile of the average distribution of all the chips. A back-
ground reduction is then performed by subtracting 2/3 of
the minimum signal value. (iii) Identification of probes
giving higher signal after selection. The software compares
Xenoarray data from transduced cells before and after the
selection, and calculates for each probe the log2 of the
ratio between the signals before and after selection. If
multiple selection experiments are conducted, the soft-
ware can compare them to identify reproducibly enriched
exogenous cDNAs. The software and user guide are avail-
able on Sourceforge [39].BMC Genomics 2008, 9:254 http://www.biomedcentral.com/1471-2164/9/254
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Analysis of Sox5 expression by PCR and western blot
For PCR, cDNA was synthesized using the RT high capac-
ity cDNA kit (Applied Biosystems), and the mouse-spe-
cific Sox-5 primers: 5'-GATATTGGGATCTCGCTGGA-3';
5'- AAGTACTGCCGCATTTCCTG-3', and the following
cycle program: 5' at 94°, followed by 25 cycles (2' at 94°-
30" at 55°- 30" at 72°), and 10' at 72°. For Western blot,
anti-human Sox5 antibody was purchased from Abcam
(Cambridge, UK). Total cellular proteins were extracted by
solubilizing the cells in boiling Laemmli buffer followed
by sonication. 100 μg of lysates were run on SDS-polyacr-
ylamide gels and transferred onto nitrocellulose mem-
branes (Hybond; GE Healthcare). Nitrocellulose-bound
antibodies were detected by the ECL system (GE Health-
care).
Sox5 cDNA cloning and expression
The full length human SOX5 cDNA was purchased from
RZPD German Resource Center for Genome Research and
the full coding sequence was cloned into the pFB retrovi-
ral vector (Stratagene). Retroviral supernatant was pro-
duced by transfecting pFB-SOX5 or pFB-hrGFP with the
pVPack-GP (gag-pol-expressing vector; Stratagene) and
the pVPack-VSV-G (env-expressing vector (Stratagene) in
293T packaging cells. The pFB-hrGFP retroviral superna-
tant was used as control of infection efficiency. MDCK
transduction with the supernatants was performed as
above.
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